Scholars discuss the regulatory landscape surrounding GLP-1 drugs and dietary supplements.

A recent study conducted in Sweden found that GLP-1 agonists such as Ozempic and Wegovy may help reduce alcohol consumption and related harms in individuals diagnosed with alcohol use disorder. Here ...

Over the past year, the question has been coming in from everywhere – from my patients and family members, from colleagues ...